estrogen-containing contraceptives have not been studied in SLE patients with moderate or severe disease activity. Antiphospholipid antibody-positive patients. Presence of aPL, with or without history of clinical complications, is a contraindication to use of estrogen-containing contraceptives due the potential further increase in thrombosis risk. We strongly recommend against combined estrogen-progestin contraceptives in women with positive aPL because estrogen increases risk of